Based on 1 analyst offering 12 month price targets for Neurosense Therapeutics Ltd
Min Forecast
$14.00+656.76%
Avg Forecast
$14.00+656.76%
Max Forecast
$14.00+656.76%
Should I buy or sell NRSN stock?
Based on 1 analyst offering ratings for Neurosense Therapeutics Ltd.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NRSN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates NRSN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More
Be the first to know when Wall Street analysts revise their NRSN stock forecasts and price targets.
Is Neurosense Therapeutics Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: NRSN) stock is to Strong Buy NRSN stock.
Out of 1 analyst, 1 (100%) are recommending NRSN as a Strong Buy, 0 (0%) are recommending NRSN as a Buy, 0 (0%) are recommending NRSN as a Hold, 0 (0%) are recommending NRSN as a Sell, and 0 (0%) are recommending NRSN as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year NRSN price target, the average NRSN price target is $14.00, with the highest NRSN stock price forecast at $14.00 and the lowest NRSN stock price forecast at $14.00.
The Wall Street analyst predicted that Neurosense Therapeutics's share price could reach $14.00 by Jul 10, 2026. The average Neurosense Therapeutics stock price prediction forecasts a potential upside of 656.76% from the current NRSN share price of $1.85.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.